GF Fund Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.8K Hold
2025
Q1
$10.6K Buy
2024
Q4
$13.4K Buy